Role of Sugar-modified Proteins in Healthy and Cancerous Cells

by Hannah Joy on  January 29, 2018 at 12:06 PM Cancer News
RSS Email Print This Page Comment bookmark
Font : A-A+

An enzyme called GalNAc-T6 present abundantly in colon cancer cells has been identified. However, this enzyme was found to be absent in healthy colon tissue, reveals a new study.
Role of Sugar-modified Proteins in Healthy and Cancerous Cells
Role of Sugar-modified Proteins in Healthy and Cancerous Cells

The enzyme appears to drive the conversion of normal colon tissue into cancer by attaching sugar molecules, or glycans, to certain proteins in the cell. Understanding the role that sugar-modified (glycosylated) proteins play in healthy and cancerous cells is an emerging area of cancer biology that may lead to new therapies.

Show Full Article


Hans Wandall's team at the University of Copenhagen studied a group of 20 enzymes that initiate the first step in a particular kind of glycan modification, called GalNAc-type O-glycosylation, found on diverse proteins. These enzymes, called GalNAc transferases (GalNAc -Ts) are variously found in different amounts in different tissues, but their functions are poorly understood.

Wandall's team, led by then-graduate student Kirstine Lavrsen, found that one of the GalNAc-Ts, called GalNAc-T6, was absent in healthy colon tissue but abundant in colon cancer cells. The report was published in the issue of the Journal of Biological Chemistry.

The team used CRISPR/Cas engineering of a colon cancer cell line with and without GalNAc-T6 to understand which proteins the enzyme helped attach sugars to, and what effect this had on the cells.

"When we look at the 3D growth of a cancer cell line that has GalNAc-T6, it can form tubular structures with formation of something that looks like colon cancer tissue," Wandall said. "When we take out GalNAc-T6, then suddenly the tissue formation changes to look more like the crypt structures that you would find in a healthy colon."

Using mass spectrometry, the team categorized the proteins that GalNAc-T6 acted on in these cells. "Our data suggest [that] this specific enzyme seems to affect a subset of proteins that could be involved in cell-cell adhesion," Wandall said.

In other words, the glycan modifications changed the patterns in which cells stuck together, leading the cells to develop as something that looked more like a tumor than a healthy tissue.

The next step, then, is to understand precisely why adding sugars to the specific protein sites modified by GalNAc-T6 leads colon cells to develop abnormally.

Glycan modifications can affect protein function in myriad ways. For example, they can make proteins that are usually cleaved into two unable to be cleaved, or prevent two proteins from binding to each other.

Wandall hopes that understanding glycosylation in cancer cells will lead to better early diagnostic tools, drugs or immunotherapies. "Glycans add an additional context layer that could help us create more specific interventions," Wandall says.

"Glycans look so different in cancer compared to normal tissue, and it's a really understudied field," Lavrsen said. "There are a lot of things to be discovered."



Source: Eurekalert

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Premium Membership Benefits

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive